NL-OMON48447CompletedNot Applicable
Immunological response after early extra and regular MMR immunization; 6 years follow-up - Early extra MMR immunization; 6 years follow-up
RIVM0 sites90 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 90
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 2 to 11 (—)
Inclusion Criteria
- •Previous participation in the study on the immunological effects of early measles vaccination, as described in a separate study protocol (NL45616.094.13/IIV-273)
- •The parents/legally representatives accept participation in the trial according to the described procedures
- •Presence of a signed informed consent
- •Children must have received their NIP vaccinations according to schedule.
Exclusion Criteria
- •Receiving immunosuppressive medication
- •Presence of a serious disease that requires medical care that can interfere with the results of the study
- •Known or suspected immunological disorder
- •Bleeding disorders
Investigators
Similar Trials
Recruiting
Not Applicable
Immunological response after early extra and regular MMR immunization; 10 years follow-upNL-OMON56402RIVM80
Not yet recruiting
Not Applicable
Immunological response after early extra and regular MMR immunization; 6 years follow-upMeasles infection, paramyxovirusNL-OMON26839RIVM105
Active, not recruiting
Phase 1
Evaluation of immunological response following a revaccination with a non-conjugated pneumococcal vaccine boosted or not by a conjugated pneumococcal vaccine in splenectomised patients (SPLENEVAC-2)Asplenic patients at risk for invasive pneumococcal diseasesMedDRA version: 20.0Level: PTClassification code 10041642Term: SplenectomySystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2018-003068-29-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)56
Not yet recruiting
Unknown
Association of immunological response with the presence or absence of oral mood stabilizers in schizophrenia patients infected with COVID-19Patients with schizophreniaJPRN-UMIN000050395Kurita hospital50
Completed
Not Applicable
Prospective study on early immune response to factor VIII exposure in previously untreated patients with severe hemophilia ABleeding disorderHaemophilia A10064477NL-OMON33198Academisch Medisch Centrum20